Celgene Corp (CELG)
Celgene engages in the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases in the United States. It operates in two segments: Human Pharmaceuticals and Stem Cell Therapies.
From their web site: "Celgene does not pay a dividend..."
- Pharmaceuticals & Biotechnology
- 🇺🇸 United States
- $68.68 yesterday's close
52 Week High0.0%10 December 2018
52 Week Low0.0%10 December 2018
Next Ex-Div-Date Countdown
|Ex-Div Date||Pay Date||Year||Type||Frequency||Status||Amount|
Celgene Corp optimized dividend - 12 month history
Celgene Corp share price - 12 month history
Try the real thing now:
You currently don't have access this feature, however you can preview the functionality.
This is a fully-functional demo intended to showcase the usefulness of this product using old data.
By proceeding you acknowledge that shown here is old data for demonstration purposes only.
To immediately activate your free account and see the live data you can log in with Facebook or LinkedIn: